All Stories

  1. Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways

    Article • Clinical Pharmacology Advances and Applications, March 2015, Taylor & Francis

    David Boothman